Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclooxygenase-2 and carcinogenesis.

S M Prescott1, F A Fitzpatrick

  • 1Department of Biochemistry, Huntsman Cancer Institute, University of Utah, Suite 4220, Building 533, 200 Circle of Hope, Salt Lake City, UT 84112-5550, USA.

Biochimica Et Biophysica Acta
|March 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of myeloperoxidase on colon tumor occurrence in inflamed versus non-inflamed colons of Apc(Min/+) mice.

Redox biology·2015
Same author

Stream Sediment Sources in Midwest Agricultural Basins with Land Retirement along Channel.

Journal of environmental quality·2015
Same author

Cardiovascular effects of platelet-activating factor.

Trends in cardiovascular medicine·2011
Same author

Genesis and "suicide" of eicosanoid biosynthetic enzymes.

Trends in cardiovascular medicine·2011
Same author

Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function.

The Journal of biological chemistry·2010
Same author

Convergence of hormones, inflammation, and energy-related factors: a novel pathway of cancer etiology.

Cancer prevention research (Philadelphia, Pa.)·2009

Cyclooxygenase-2 (COX-2) plays a key role in colon cancer development. Inhibiting COX-2 may prevent tumor formation and improve outcomes, suggesting NSAIDs for cancer prevention.

Area of Science:

  • Oncology
  • Molecular Biology
  • Gastroenterology

Background:

  • Cyclooxygenase-2 (COX-2) is implicated in colon carcinogenesis, particularly following APC tumor suppressor mutations.
  • COX-2 expression levels correlate with tumor size and invasiveness, highlighting its significance in colorectal cancer progression.

Purpose of the Study:

  • To explore the role of COX-2 in colon cancer development and progression.
  • To evaluate the potential of COX-2 inhibition for colon cancer prophylaxis and treatment.

Main Methods:

  • Review of existing investigations on COX-2 in colon carcinogenesis.
  • Correlation analysis of COX-2 expression levels with tumor characteristics.

Main Results:

  • Early-stage COX-2 inhibition blocks malignant tumor development.

Related Experiment Videos

  • Inhibition of COX-2 leads to regression of pre-malignant tumors.
  • COX-2 inhibition may improve outcomes in established colon cancer.

    • Conclusions:

    • Chronic inflammation, through increased COX-2, promotes tumor formation.
    • Existing NSAIDs show promise for the prophylaxis of colon cancer and polyps.
    • Further clinical investigations are needed to establish guidelines for NSAID therapy in colon cancer prevention.